Key result
Antihypertensive use shows minimal association with HRQoL in youth with CKD and hypertension.
Why the study?
Controlling blood pressure is essential for slowing CKD progression, but the associations between antihypertensive treatment burden and HRQoL in youth with CKD and hypertension are unclear.
Cross-Sectional (n=395)
Yes
Supports prioritizing BP control in youth CKD without QoL trade-offs; leaves open causal effects pending prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Botdorf et al. (2026) conducted a cross-sectional in Chronic kidney disease and hypertension (n=395). Antihypertensive medication use was evaluated on Health-related quality of life (HRQoL) and related well-being domains. Antihypertensive medication use showed minimal association with health-related quality of life among youth with chronic kidney disease and hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: